Exome Asset Management LLC Portfolio Holdings

Exome Asset Management LLC

  • $135 Billion
  • Q2 2025

Exome Asset Management LLC has filed its 13F form on August 15, 2025 for Q2 2025 where it was disclosed a total value porftolio of $135 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Tr with a value of $7.35B, Bridge Bio Pharma, Inc. with a value of $6.72B, Guardant Health, Inc. with a value of $5.11B, Geron Corp with a value of $4.81B, and Ionis Pharmaceuticals Inc with a value of $4.79B.

Exome Asset Management LLC is based out at New York, NY

Below you can find more details about Exome Asset Management LLC portfolio as well as his latest detailed transactions.

Portfolio value $135 Billion
Healthcare: $99.6 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Ishares Tr
-
$7.35 Billion 5.47% of portfolio
-
Q2 2025 New
$7.63B
$6.72 Billion 4.99% of portfolio
155,533
Q2 2025 Reduced 6.02%
$5.6B
$5.11 Billion 3.8% of portfolio
98,182
Q2 2025 Reduced 22.8%
$480M
$4.81 Billion 3.58% of portfolio
3,414,377
Q2 2025 Added 6.19%
$8.67B
$4.79 Billion 3.56% of portfolio
121,116
Q2 2025 Reduced 10.69%
$20.1B
$4.75 Billion 3.53% of portfolio
27,000
Q2 2025 New
$4.65B
$3.83 Billion 2.85% of portfolio
115,817
Q2 2025 Added 11.92%
$816M
$3.83 Billion 2.85% of portfolio
533,647
Q2 2025 Reduced 14.16%
$280M
$3.7 Billion 2.75% of portfolio
397,846
Q2 2025 Added 34.93%
$711B
$3.64 Billion 2.71% of portfolio
4,673
Q1 2025 Reduced 43.34%
Soleno Therapeutics Inc
-
$3.49 Billion 2.59% of portfolio
-
Q2 2025 Reduced 4.14%
$153B
$3.46 Billion 2.57% of portfolio
6,358
Q1 2025 Reduced 14.39%
Disc Medicine Inc
-
$3.25 Billion 2.42% of portfolio
-
Q2 2025 Reduced 0.49%
$16.7B
$3.15 Billion 2.34% of portfolio
18,650
Q1 2025 Reduced 16.93%
$368M
$3.06 Billion 2.28% of portfolio
444,949
Q2 2025 Reduced 35.43%
$1.68B
$2.99 Billion 2.22% of portfolio
84,339
Q1 2025 Added 8.91%
Verastem Inc
-
$2.49 Billion 1.85% of portfolio
-
Q2 2025 New
Praxis Precision Medicines I
-
$2.48 Billion 1.84% of portfolio
-
Q2 2025 New
$9.97B
$2.31 Billion 1.72% of portfolio
9,000
Q4 2024 New
$376M
$2.29 Billion 1.7% of portfolio
233,426
Q2 2025 Reduced 34.04%
$1.48B
$2.27 Billion 1.69% of portfolio
153,278
Q2 2025 Added 29.88%
$2.08B
$2.19 Billion 1.63% of portfolio
166,944
Q2 2025 Added 16.95%
Nektar Therapeutics
-
$1.94 Billion 1.44% of portfolio
-
Q2 2025 New
Waystar Hldg Corp
-
$1.92 Billion 1.43% of portfolio
-
Q2 2025 New
Corbus Pharmaceuticals Hldgs
-
$1.91 Billion 1.42% of portfolio
-
Q2 2025 Reduced 4.27%
$1.27B
$1.9 Billion 1.41% of portfolio
163,658
Q2 2025 New
$666M
$1.87 Billion 1.39% of portfolio
195,933
Q2 2025 Reduced 24.17%
$393M
$1.86 Billion 1.38% of portfolio
226,060
Q2 2025 Reduced 44.22%
$12.5B
$1.83 Billion 1.36% of portfolio
10,100
Q2 2025 New
$656M
$1.81 Billion 1.34% of portfolio
76,700
Q2 2025 New
$1.82B
$1.8 Billion 1.34% of portfolio
62,700
Q2 2025 Added 22.23%
$2.68B
$1.71 Billion 1.27% of portfolio
98,600
Q2 2025 New
Travere Therapeutics Inc
-
$1.63 Billion 1.21% of portfolio
-
Q2 2025 New
$865M
$1.63 Billion 1.21% of portfolio
124,470
Q2 2025 Added 74.24%
$1.43B
$1.55 Billion 1.15% of portfolio
172,883
Q2 2025 Added 185.29%
Karyopharm Therapeutics Inc
-
$1.52 Billion 1.13% of portfolio
-
Q1 2025 New
$1.15B
$1.49 Billion 1.1% of portfolio
73,000
Q2 2025 New
Sarepta Therapeutics Inc
-
$1.45 Billion 1.07% of portfolio
-
Q2 2025 New
$299M
$1.35 Billion 1.0% of portfolio
1,097,999
Q4 2024 Added 134.37%
Structure Therapeutics Inc
-
$1.11 Billion 0.83% of portfolio
-
Q2 2025 Reduced 47.79%
$5.67B
$1.03 Billion 0.77% of portfolio
29,100
Q2 2025 New
Mbx Biosciences Inc
-
$720 Million 0.54% of portfolio
-
Q2 2025 Reduced 52.61%
$2B
$715 Million 0.53% of portfolio
78,372
Q2 2025 Reduced 13.02%
-
$662 Million 0.49% of portfolio
-
Q2 2025 New
$363M
$598 Million 0.44% of portfolio
213,544
Q2 2025 New
$894M
$560 Million 0.42% of portfolio
13,100
Q4 2024 Reduced 39.63%
Vyne Therapeutics Inc
-
$345 Million 0.26% of portfolio
-
Q2 2025 Reduced 54.85%
Anaptysbio Inc
-
$333 Million 0.25% of portfolio
-
Q2 2025 Reduced 87.14%
Instil Bio Inc
-
$337 Million 0.25% of portfolio
-
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $135 Billion
  • Prior Value $135 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 15, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 5 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email